Point72 Asset Management’s Ascentage Pharma AAPG Stock Holding History

Point72 Asset Management’s Portfolio AAPG Stock Details AAPG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$243K	Sell	13,841 -2,215	-14%	-$47.2K	﹤0.01%	3455
2026 Q1	$383K	Sell	16,056 -670	-4%	-$16.5K	﹤0.01%	3253
2025 Q4	$439K	Buy	+16,726	New	+$548K	﹤0.01%	3300

Other funds holding AAPG

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Point72 Asset Management's AAPG Position: Q2 2026 in Review

Point72 Asset Management reduced its Ascentage Pharma (AAPG) stake by 14% in Q2 2026, selling an estimated $47.2K and leaving 13,841 shares worth $243K. The position accounts for ﹤0.01% of the portfolio, ranked #3455.

Point72 Asset Management first reported a position in AAPG in Q4 2025 and has held it in 3 quarters since. The position peaked at $439K in Q4 2025. 8 funds tracked by Wall St. Rank hold AAPG as of Q2 2026.

Point72 Asset Management held 13,841 shares of Ascentage Pharma worth $243K as of Q2 2026.
Point72 Asset Management sold 2,215 Ascentage Pharma shares in Q2 2026, an estimated $47.2K.
Ascentage Pharma made up ﹤0.01% of Point72 Asset Management's portfolio in Q2 2026, its #3455 holding.
Point72 Asset Management first reported a position in Ascentage Pharma in Q4 2025 and has held it in 3 quarters since.
Point72 Asset Management's Ascentage Pharma position peaked at $439K in Q4 2025.
8 funds tracked by Wall St. Rank held Ascentage Pharma as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.